persistent allergic rhinitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) patients who meet the diagnostic criteria of Western medicine and TCM syndrome differentiation standard; (2) aged 18 to 60 years; (3) voluntary participation in this study, voluntary termination of all treatment may affect the assessment of the drug; (4) to sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) oral administration of steroids in recent 2 weeks and oral administration of anti histamine drugs or topical steroids in recent 1 week; (2) with severe deviation of nasal septum, hypertrophic rhinitis; (3) patients with asthma; (4) patients with severe primary diseases, such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; (5) patients with mental illness; (6) allergic to the drug; (7) pregnancy, lactation or preparation of pregnant women; (8) patients who do not meet the inclusion criteria or prescribed medication or incomplete data; (9) less than 28 days of treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Six symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM symptom score;RQLQ score; | — |
Countries
China
Contacts
Beijing Tongren hospital affiliated to Capital Medical University